Anti-FMN2 monoclonal antibody

Anti-FMN2 antibody for FACS & in-vivo assay

Target products collectionGo to FMN2/FMN2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2130-Ab-1/ GM-Tg-hg-MP2130-Ab-2Anti-Human FMN2 monoclonal antibodyHuman
GM-Tg-rg-MP2130-Ab-1/ GM-Tg-rg-MP2130-Ab-2Anti-Rat FMN2 monoclonal antibodyRat
GM-Tg-mg-MP2130-Ab-1/ GM-Tg-mg-MP2130-Ab-2Anti-Mouse FMN2 monoclonal antibodyMouse
GM-Tg-cynog-MP2130-Ab-1/ GM-Tg-cynog-MP2130-Ab-2Anti-Cynomolgus/ Rhesus macaque FMN2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2130-Ab-1/ GM-Tg-felg-MP2130-Ab-2Anti-Feline FMN2 monoclonal antibodyFeline
GM-Tg-cang-MP2130-Ab-1/ GM-Tg-cang-MP2130-Ab-2Anti-Canine FMN2 monoclonal antibodyCanine
GM-Tg-bovg-MP2130-Ab-1/ GM-Tg-bovg-MP2130-Ab-2Anti-Bovine FMN2 monoclonal antibodyBovine
GM-Tg-equg-MP2130-Ab-1/ GM-Tg-equg-MP2130-Ab-2Anti-Equine FMN2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2130-Ab-1/ GM-Tg-hg-MP2130-Ab-2; GM-Tg-rg-MP2130-Ab-1/ GM-Tg-rg-MP2130-Ab-2;
GM-Tg-mg-MP2130-Ab-1/ GM-Tg-mg-MP2130-Ab-2; GM-Tg-cynog-MP2130-Ab-1/ GM-Tg-cynog-MP2130-Ab-2;
GM-Tg-felg-MP2130-Ab-1/ GM-Tg-felg-MP2130-Ab-2; GM-Tg-cang-MP2130-Ab-1/ GM-Tg-cang-MP2130-Ab-2;
GM-Tg-bovg-MP2130-Ab-1/ GM-Tg-bovg-MP2130-Ab-2; GM-Tg-equg-MP2130-Ab-1/ GM-Tg-equg-MP2130-Ab-2
Products NameAnti-FMN2 monoclonal antibody
Formatmab
Target NameFMN2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FMN2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FMN2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2130
    Target NameFMN2
    Gene ID56776,54418,100360457,708376,490366,101097037,100060203
    Gene Symbol and SynonymsAABR07021812.1,FMN2
    Uniprot AccessionQ9NZ56
    Uniprot Entry NameFMN2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000155816
    Target ClassificationN/A

    The target: FMN2, gene name: FMN2, also named as . This gene is a member of the formin homology protein family. The encoded protein is thought to have essential roles in organization of the actin cytoskeleton and in cell polarity. This protein mediates the formation of an actin mesh that positions the spindle during oogenesis and also regulates the formation of actin filaments in the nucleus. This protein also forms a perinuclear actin/focal-adhesion system that regulates the shape and position of the nucleus during cell migration. Mutations in this gene have been associated with infertility and also with an autosomal recessive form of intellectual disability (MRT47). Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jul 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.